ZLSCF (ZYUS Life Sciences) EPS (Basic) : $-0.33 (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences EPS (Basic)?

ZYUS Life Sciences's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was $-0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.33.

ZYUS Life Sciences's EPS (Diluted) for the three months ended in Mar. 2025 was $-0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.33.

ZYUS Life Sciences's EPS without NRI for the three months ended in Mar. 2025 was $-0.04. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.16.

During the past 3 years, the average EPS without NRI Growth Rate was 16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, ZYUS Life Sciences's highest 3-Year average EPS without NRI Growth Rate was 16.60% per year. The lowest was 16.60% per year. And the median was 16.60% per year.

ZYUS Life Sciences EPS (Basic) Historical Data

The historical data trend for ZYUS Life Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences EPS (Basic) Chart

ZYUS Life Sciences Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

-0.26

-0.57

-0.33

ZYUS Life Sciences Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial								-0.04	-0.05	-0.04	-0.21	-0.04

ZYUS Life Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

ZYUS Life Sciences's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-23.728	-	0)	/	72.065
	=	-0.33

ZYUS Life Sciences's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-2.758	-	0)	/	74.358
	=	-0.04

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.33

ZYUS Life Sciences (OTCPK:ZLSCF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ZYUS Life Sciences EPS (Basic) Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

ZYUS Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (OTCPK:ZLSCF) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

ZYUS:Canada

Address

407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8

Website

https://www.zyus.com

ZYUS Life Sciences Corp is primarily engaged in the world-wide development and commercialization of cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada. The company has one reportable segment: Bio-pharmaceutical Products (including medical cannabis derivatives). Geographically, it operates in Canada; United States; Australia; and European Union.

ZYUS Life Sciences Headlines

No Headlines